Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer

by Tyrillshall S. T. Damiana, Simone U. Dalm
Published 2021-05-01

Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?

by Simone U. Dalm, Marion de Jong
Published 2017-09-01

Therapeutic Applications of Pretargeting

by Marjolein Verhoeven, Yann Seimbille, Simone U. Dalm
Published 2019-09-01

Review: Receptor Targeted Nuclear Imaging of Breast Cancer

by Simone U. Dalm, John Fred Verzijlbergen, Marion De Jong
Published 2017-01-01

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy

by Sofia Koustoulidou, Mark W. H. Hoorens, Simone U. Dalm, Shweta Mahajan, Reno Debets, Yann Seimbille, Marion de Jong
Published 2021-03-01

DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells.

by Sanne R Martens-de Kemp, Simone U Dalm, Fiona M J Wijnolts, Arjen Brink, Richard J Honeywell, Godefridus J Peters, Boudewijn J M Braakhuis, Ruud H Brakenhoff
Published 2013-01-01

Progressive APOBEC3B mRNA expression in distant breast cancer metastases.

by Anieta M Sieuwerts, Willemijne A M E Schrijver, Simone U Dalm, Vanja de Weerd, Cathy B Moelans, Natalie Ter Hoeve, Paul J van Diest, John W M Martens, Carolien H M van Deurzen
Published 2017-01-01

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.

by Simone U Dalm, Willemijne A M E Schrijver, Anieta M Sieuwerts, Maxime P Look, Angelique C J Ziel-van der Made, Vanja de Weerd, John W Martens, Paul J van Diest, Marion de Jong, Carolien H M van Deurzen
Published 2017-01-01